Leadership Overview
Recursion has 5 executives leading key functions including strategy, operations, medicine, communications, and business operations.
Driven by a mission to industrialize drug discovery, Recursion decodes biology by integrating technological innovations across biology, chemistry, automation, machine learning, and engineering to radically improve patient lives.
Driven by a mission to industrialize drug discovery, Recursion decodes biology by integrating technological innovations across biology, chemistry, automation, machine learning, and engineering to radically improve patient lives.
Leadership Roles at Recursion
Najat Khan - Chief Executive Officer, President & Member, Board of Directors
Najat Khan, the Chief Executive Officer, President & Member, Board of Directors at Recursion, directs the company's overarching strategy and operational execution. This leadership role involves guiding Recursion's mission to industrialize drug discovery through advanced technological integration. Khan oversees the development and deployment of the Recursion Operating System, a proprietary platform generating extensive biological and chemical datasets. This executive drives the exploration of foundational biology, utilizing the Recursion Map to uncover novel biological insights unconstrained by human bias. Najat Khan ensures alignment across all departments, fostering innovation in biology, chemistry, automation, machine learning, and engineering to achieve the goal of radically improving patient lives. The Chief Executive Officer, President & Member, Board of Directors role is central to navigating the complexities of clinical-stage biotechnology and positioning Recursion for significant market impact.
Madeleine Lyman - Executive Business Partner To Ben Taylor. Chief Financial Officer and Sid Jain
Madeleine Lyman, the Executive Business Partner To Ben Taylor. Chief Financial Officer and Sid Jain at Recursion, provides essential support to key financial and operational leadership. This position is integral to ensuring the smooth functioning of the finance department and its strategic initiatives. Lyman facilitates communication and coordination between the Chief Financial Officer, Sid Jain, and other critical stakeholders, enabling efficient decision-making. The Executive Business Partner To Ben Taylor. Chief Financial Officer and Sid Jain role supports the company's broader mission of industrializing drug discovery by ensuring financial operations are robust and aligned with technological advancements. Madeleine Lyman's contributions are key to managing complex projects and maintaining operational continuity within Recursion's clinical-stage biotechnology framework. This support is crucial for advancing the company's goal of radically improving patient lives.
Emma Holtman - Chief of Staff & Executive & Business Partner
Emma Holtman, the Chief of Staff & Executive & Business Partner at Recursion, provides critical operational support and strategic alignment across executive functions. This role involves facilitating seamless communication and workflow between leadership teams, ensuring efficient execution of company initiatives. Holtman manages key projects and drives strategic planning processes, directly supporting the company's mission to industrialize drug discovery. The Chief of Staff & Executive & Business Partner ensures that technological innovations in biology, chemistry, automation, machine learning, and engineering are effectively integrated. Emma Holtman's responsibilities include optimizing operational efficiency and supporting the leadership team in navigating the complexities of clinical-stage biotechnology. This executive partner role is vital for maintaining momentum and achieving Recursion's goal of radically improving patient lives through data-driven biological insights.
Vicki Goodman - Chief Medical Officer
Vicki Goodman, the Chief Medical Officer at Recursion, leads the clinical development strategy and execution for the company's drug discovery pipeline. This critical role involves translating biological insights into tangible therapeutic solutions, directly supporting Recursion's mission to radically improve patient lives. Goodman oversees the design and implementation of clinical trials, ensuring adherence to regulatory standards and scientific rigor. The Chief Medical Officer integrates findings from Recursion's advanced datasets and machine learning tools to identify promising drug candidates. Vicki Goodman's expertise guides the company's approach to decoding biology and navigating the complexities of clinical-stage biotechnology. This leadership ensures that technological innovations are effectively applied to develop novel treatments and achieve significant therapeutic impact.
Ryan Kelly - Chief Communications Officer & Leadership Executive & Team Member
Ryan Kelly, the Chief Communications Officer & Leadership Executive & Team Member at Recursion, directs the company's external and internal communication strategies. This role is pivotal in articulating Recursion's mission to industrialize drug discovery and its technological innovations to diverse audiences, including investors, partners, and the public. Kelly oversees the development and dissemination of key messages, ensuring consistent and impactful representation of the company's progress and vision. The Chief Communications Officer & Leadership Executive & Team Member plays a crucial part in shaping Recursion's brand identity and fostering stakeholder engagement. Ryan Kelly's leadership ensures that the company's commitment to decoding biology and radically improving patient lives is clearly communicated. This executive ensures that Recursion's advancements in biology, chemistry, automation, machine learning, and engineering are understood and valued across the industry.
Explore Leadership Teams in Business Services
Velocity Clinical Research, headquartered in Durham, NC, is a leading integrated site organization for clinical trials, offering dedicated site capabilities to help biopharmaceutical and contract research organization customers find the right patients for their studies.
Company Leadership GC
Lloyd's Register Group Limited (LR) is a technical and professional services organisation and a maritime classification society, wholly owned by the Lloyds Register Foundation, a UK charity dedicated to research and education in science and engineering. The organisation dates to 1760. Its stated aims are to enhance the safety of life, property, and the environment, by helping its clients (including by validation, certification, and accreditation) to improve the safety and performance of complex projects, supply chains and critical infrastructure. In July 2012, the organisation converted from an industrial and provident society to a company limited by shares, named Lloyds Register Group Limited, with the new Lloyds Register Foundation as the sole shareholder. At the same time the organisation gave to the Foundation a substantial bond and equity portfolio to assist it with its charitable purposes. It will benefit from continued funding from the groups operating arm, Lloyds Register Group Limited. In 2020, Lloyd's Register sold its Energy business Lloyd's Register is unaffiliated with Lloyd's of London, but emerged from the same professional and social circles that historically met at Lloyd's Coffee House, from which both organisations took their name.
Company Leadership ST
JH
DC
Microbac Laboratories is a provider of laboratory testing for environmental, food and life sciences. Microbac was founded in 1969 and is currently headquartered in Pittsburgh, PA
Company Leadership
RA
DF
CL
Genewiz is an R&D genomics services company providing Sanger DNA sequencing, gene synthesis, molecular biology, high throughput/next-generation sequencing, bioinformatics, and GLP regulatory services. The company was founded in 1999 and is headquartered in South Plainfield, New Jersey.
Company Leadership SV
JD
LL
Frequently Asked Questions Regarding Recursion Top Executives and Leadership Team
